Latest Videos |view all videos
Methylated DNA markers and whole-body cancer screening
John B. Kisiel, M.D., a gastroenterologist at Mayo Clinic's campus in Rochester, Minnesota, discusses a study that identified the source of cancer in patients' gastrointestinal tracts by analyzing DNA markers from tumors.
Researchers locate master cutoff switch for cancer-causing HER2 protein
Herceptin has been touted as a wonder drug for women with HER2-positive breast cancer, an aggressive form of the disease that is fueled by excess production of the HER2 protein.
Ibrutinib with chemotherapy offers longer life to people with B-Cell cancers
Researchers found that a combination of ibrutinib and chemotherapy reduced the risk of death or cancer progression by 80 percent in people with previously treated chronic lymphocytic leukemia.
Proton therapy has advantages over IMRT for advanced nasal cavity and paranasal sinus cancer
Robert L. Foote, M.D., comments on findings of a new study by radiation oncologists at Mayo Clinic, comparing the world's literature on outcomes of proton beam therapy in the treatment of a variety of advanced head and neck cancers of the skull base.
Minimally invasive inguinal lymph node dissection (MILND)
Jakub James, M.D., demonstrates the operative technique of minimally invasive inguinal lymph node dissection in patients with melanoma. This video is intended for a surgical audience and is not intended to replace hands-on training.
Treatment for people with cholangiocarcinoma at Mayo Clinic
Rory L. Smoot, M.D., describes treatment options and the specialized team of experts at Mayo Clinic who provide care for patients with cholangiocarcinoma.
Bladder cancer treatment options
R. Jeffrey Karnes, M.D., consultant and associate professor, Mayo Clinic, discusses treatment options for bladder cancer. The ailment can be subdivided into subcategories, and the treatments dramatically differ. Invasive treatments can ...
Combined Therapy Benefits Cigarette Smokers Trying to Quit Compared to Monotherapy
Jon Ebbert, M.D., of the Mayo Clinic Nicotine Dependence Center, on a study combining the smoking cessation medications varenicline and bupropion, compared with varenicline alone, that resulted in higher smoking abstinence rates.
Expert comments on Surgeon General report about smoking
Richard D. Hurt, M.D., director of Mayo Clinic's Nicotine Dependence Center, comments on a new report by the Surgeon General released Jan. 2014, The Health Consequences of Smoking — 50 Years of Progress, which highlights a half-century ...
Mayo Clinic scientists propose a breast cancer drug for bladder cancer patients
Amplification of HER2, a known driver of some breast cancers, in a type of bladder cancer called micropapillary urothelial carcinoma (MPUC), has shown that the presence of HER2 amplification is associated with particularly aggressive tumors.
Mayo Clinic researchers find 2 oncogenes join to drive lung squamous cell carcinoma
Alan P. Fields, Ph.D., and Dr. Monica Flynn Jacoby, professor of cancer studies at Mayo Clinic's campus in Florida, talk about the publication of his team's latest discovery.
Judy C. Boughey, M.D., and Matthew P. Goetz, M.D., present Breast Cancer Genome-Guided Therapy Study: Next-Generation Sequencing for the Management of Women With High-Risk Breast Cancer.